{
    "2021-05-12": [
        [
            {
                "time": "",
                "original_text": "同写意丨药明直播间—苗头化合物系列(六)：DNA编码化合物库技术助力共价抑制剂的发现",
                "features": {
                    "keywords": [
                        "药明",
                        "DNA编码化合物库",
                        "共价抑制剂",
                        "发现"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药代表年薪哪家强？最高原来是这家！",
                "features": {
                    "keywords": [
                        "医药代表",
                        "年薪"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "牛人重仓｜564只基金持有3.36亿股，融资客暴买：葛兰第1大重仓股入选指数！",
                "features": {
                    "keywords": [
                        "基金",
                        "重仓股",
                        "葛兰",
                        "指数"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明、康龙、泰格、昭衍4家“A+H”股CRO业绩大涨，中国企业增长超越全球TOP5",
                "features": {
                    "keywords": [
                        "药明",
                        "康龙",
                        "泰格",
                        "昭衍",
                        "CRO",
                        "业绩",
                        "增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年报及2021年一季度回顾：“疫”后归来 再望佳期",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2020年报",
                        "2021年一季度",
                        "疫情"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智氪 | 业绩创新高，估值腰斩，「药茅台」是否还值得买？",
                "features": {
                    "keywords": [
                        "业绩",
                        "估值",
                        "药茅台"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年年报＆2021Q1季报小结及前瞻：业绩恢复强劲 高景气赛道表现亮眼",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2020年年报",
                        "2021Q1季报",
                        "业绩",
                        "高景气赛道"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "明日下午3点！DNA编码化合物库技术助力共价抑制剂的发现",
                "features": {
                    "keywords": [
                        "DNA编码化合物库",
                        "共价抑制剂",
                        "发现"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中泰证券：国内CRO/CDMO行业全面恢复，把握具备长期成长性的板块优质公司",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "CRO",
                        "CDMO",
                        "行业恢复",
                        "长期成长性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}